Pulse Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.54 Cr
- Paid Up Capital ₹ 7.94 Cr
- Company Age 28 Year, 24 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 118.34 Cr
- Satisfied Charges ₹ 6.00 Cr
- Revenue Growth 7.30%
- Profit Growth 19.52%
- Ebitda 3.76%
- Net Worth 21.67%
- Total Assets 38.08%
About Pulse Pharmaceuticals
Pulse Pharmaceuticals Private Limited (PPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 January 1997 and has a history of 28 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.54 Cr and a paid-up capital of Rs 7.94 Cr.
The company currently has active open charges totaling ₹118.34 Cr. The company has closed loans amounting to ₹6.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pulse Pharmaceuticals Private Limited India is Ramesh Surampudi as COMPANY SECRETARY. Venkat Katragadda, Suresh Katragadda, Srikanth Myneni, and Three other members serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24239TG1997PTC026151
-
Company No.
026151
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jan 1997
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Pulse Pharmaceuticals Private Limited offer?
Pulse Pharmaceuticals Private Limited offers a wide range of products and services, including Antiparasitic Drug, Ivermectin Tablets, Paracetamol Tablets, Paracip Tablets.
Who are the key members and board of directors at Pulse Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Surampudi
|
Company Secretary | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Rambhau Devraj
|
Director | 01-Jun-2015 | Current |
|
Venkat Katragadda
|
Director | 09-Jan-1997 | Current |
|
Suresh Katragadda
|
Director | 24-Feb-2004 | Current |
|
Srikanth Myneni
|
Director | 01-Sep-2017 | Current |
|
Venkateswarlu Nelabhotla
|
Director | 10-Nov-2022 | Current |
|
Divya Katragadda
|
Director | 09-May-2019 | Current |
Financial Performance of Pulse Pharmaceuticals.
Pulse Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.3% increase. The company also saw a substantial improvement in profitability, with a 19.52% increase in profit. The company's net worth Soared by an impressive increase of 21.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pulse Pharmaceuticals?
In 2023, Pulse Pharmaceuticals had a promoter holding of 70.59% and a public holding of 29.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vyome Therapeutics LimitedVenkateswarlu Nelabhotla is a mutual person
-
Vyome Biosciences Private LimitedVenkateswarlu Nelabhotla is a mutual person
-
Vizag International Private LimitedSrikanth Myneni is a mutual person
-
Medzara Healthtech Private LimitedVenkateswarlu Nelabhotla is a mutual person
-
Pulse Nutri Science Private LimitedVenkat Katragadda and Suresh Katragadda are mutual person
-
Srishti Udyog LlpSrikanth Myneni is a mutual person
Charges (Loans)
₹118.34 Cr
₹6.00 Cr
Charges Breakdown by Lending Institutions
- Others : 116.91 Cr
- Hdfc Bank Limited : 0.77 Cr
- Axis Bank Limited : 0.66 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2023 | Others | ₹5.00 Cr | Open |
| 31 Jul 2023 | Others | ₹1.49 Cr | Open |
| 28 May 2023 | Others | ₹1.40 Cr | Open |
| 28 Mar 2023 | Others | ₹7.00 Cr | Open |
| 18 Feb 2022 | Others | ₹30.00 Cr | Open |
How Many Employees Work at Pulse Pharmaceuticals?
Pulse Pharmaceuticals has a workforce of 996 employees as of May 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pulse Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pulse Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
